Longs - Please keep this in mind. A little reality check :)
Just after the MAKO piece and all the other BS:
July 17th 2015 - $3.36 - SHARE PRICE
August 2015 OS - 118,170,536
Cash - $8.4 Million
Sept 30th 2015 - Still had 28.2 Million from Aspire
Proprietary Program
Indication
Clinical Status
1.
Kevetrin
Inhibitor for Solid Tumors (ONGOING)
Phase 1
2.
Prurisol
Psoriasis
Phase 2A (ONGOING)
3.
Brilacidin
ABSSSI
Phase 2 Completed
4.
Brilacidin - OM
Oral Mucositis
Phase 2 (ONGOING - Just started)
FAST FORWARD ------------------->
February 2017 - Share Price - .93 CENTS
January 2017 OS - 126,408,756
CASH - 3.9 Million
Dec 31st 2016 - Still had 19 million from Aspire
Proprietary Program
Indication
Clinical Status
1.
Kevetrin
Ovarian Phase 2A Trial Recruiting - 10 Patients 2 Cohorts (5 in each)
3X's a week dosing starting at 250mg/m2 compared to Phase 1 which started at 10mg/m2 once a week. THIS COULD BE HUGE!!!
2.
Prurisol
Psoriasis
Phase 2B - Recruiting - 189 Patients; Double the dose from the successful 200mg Phase 2A
Powered Study - Using same scale as most competitors (PASI) and dosing Moderate to Severe - Much more likely to succeed. THIS COULD BE HUGE!!!
3.
Brilacidin
ABSSSI
Phase 3 - SPA on hold until share price rebounds (Partner at anytime)
4.
Brilacidin - OM
Oral Mucositis
Phase 2 - Ongoing - Interim Data due out in 5-7 weeks. THIS COULD BE HUGE!!!
5.
Brilacidin - UP/UC
Currently in 2nd Cohort of 3 Cohorts. Data expected on 2nd Cohort in 1 week. So far excellent Data. THIS COULD BE HUGE!!! If again successful this could show that B-OM is on track to be a winner!
SUMMARY ------>
Down about 4.5 Million in cash - Diluted about 8 Million in OS, but ALL trials are on track to succeed and we have actually moved forward on all fronts. We added huge names to the companies MGMT team and have added several CDA's with BP.
I don't see how anyone in their right mind could justify the market value of CTIX compared to where it was and prior. We are days/weeks/months away from our first major partnership. Hold tight my friends and add willingly.
Go CTIX!
